U.S. - Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
Report Update: Mar 1, 2025

U.S. - Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Penicillins Or Streptomycins Medicaments Prices in the United States

U.S. Penicillins Or Streptomycins Medicaments Import Price per Ton in August 2022

In August 2022, the penicillins or streptomycins medicaments price per ton amounted to $48.9K (CIF, US), with a decrease of -35% against the previous month. Overall, the import price recorded a abrupt contraction. The most prominent rate of growth was recorded in April 2022 an increase of 43% m-o-m. As a result, import price attained the peak level of $97.0K per ton. From May 2022 to August 2022, the average import prices failed to regain momentum.

Prices varied noticeably by the country of origin: the country with the highest price was India ($70.2K per ton), while the price for Slovenia ($27.8K per ton) was amongst the lowest.

From January 2022 to August 2022, the most notable rate of growth in terms of prices was attained by Jordan (+3.2%), while the prices for the other major suppliers experienced more modest paces of growth.

U.S. Penicillins Or Streptomycins Medicaments Imports

Penicillins or streptomycins medicaments imports into the United States skyrocketed to 687 tons in August 2022, surging by 41% on the previous month. The total import volume increased at an average monthly rate of +2.6% over the period from January 2022 to August 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain months. As a result, imports attained the peak and are likely to continue growth in the immediate term.

In value terms, penicillins or streptomycins medicaments imports fell to $34M (IndexBox estimates) in August 2022. Overall, imports, however, showed a abrupt curtailment. The most prominent rate of growth was recorded in July 2022 with an increase of 39% against the previous month.

U.S. Penicillins Or Streptomycins Medicaments Imports by Country

China (141 tons), Italy (137 tons) and India (133 tons) were the main suppliers of penicillins or streptomycins medicaments imports to the United States, with a combined 60% share of total imports.

From January 2022 to August 2022, the biggest increases were in China (with a CAGR of +18.0%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest penicillins or streptomycins medicaments suppliers to the United States were India ($9.4M), Italy ($8.2M) and Austria ($5.1M), with a combined 68% share of total imports.

In terms of the main suppliers, Italy, with a CAGR of +8.5%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced mixed trend patterns.

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201160 - Medicaments of penicillins, streptomycins or derivatives thereof, in doses or p.r.s.

Country coverage:

  • United States

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in the U.S.
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2024
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2024
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2024
    2. Market Volume, In Physical Terms, 2012–2024
    3. Market Value, 2012–2024
    4. Per Capita Consumption In 2012-2024
    5. Imports, In Physical Terms, By Country, 2012–2024
    6. Imports, In Value Terms, By Country, 2012–2024
    7. Import Prices, By Country Of Origin, 2012–2024
    8. Exports, In Physical Terms, By Country, 2012–2024
    9. Exports, In Value Terms, By Country, 2012–2024
    10. Export Prices, By Country Of Destination, 2012–2024
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2024
    2. Market Value, 2012–2024
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2024
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2024
    5. Trade Balance, In Physical Terms, 2012-2024
    6. Trade Balance, In Value Terms, 2012-2024
    7. Per Capita Consumption, 2012-2024
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2024
    22. Production, In Value Terms, 2012–2024
    23. Imports, In Physical Terms, 2012–2024
    24. Imports, In Value Terms, 2012–2024
    25. Imports, In Physical Terms, By Country, 2024
    26. Imports, In Physical Terms, By Country, 2012–2024
    27. Imports, In Value Terms, By Country, 2012–2024
    28. Import Prices, By Country Of Origin, 2012–2024
    29. Exports, In Physical Terms, 2012–2024
    30. Exports, In Value Terms, 2012–2024
    31. Exports, In Physical Terms, By Country, 2024
    32. Exports, In Physical Terms, By Country, 2012–2024
    33. Exports, In Value Terms, By Country, 2012–2024
    34. Export Prices, By Country Of Destination, 2012–2024
Store
Blog
Event
U.S. - Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Mar 1, 2025
Eye 294

This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in the U.S..

U.S. - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends And Insights
$599
Mar 1, 2025
Eye 285

This report provides an in-depth analysis of the market for medicaments containing corticosteroid hormones in the U.S..

U.S. - Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Market Analysis, Forecast, Size, Trends And Insights
$599
Mar 1, 2025
Eye 300

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..

U.S. - Medicaments Containing Vitamins And Provitamins - Market Analysis, Forecast, Size, Trends And Insights
$599
Mar 1, 2025
Eye 273

This report provides an in-depth analysis of the medicaments containing vitamins market in the U.S..

World - Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Mar 1, 2025
Eye 366

This report provides an in-depth analysis of the global market for penicillins or streptomycins medicaments.

World - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends And Insights
$599
Mar 1, 2025
Eye 381

This report provides an in-depth analysis of the global market for medicaments containing corticosteroid hormones.

World - Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Market Analysis, Forecast, Size, Trends And Insights
$599
Mar 1, 2025
Eye 360

This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.

World - Medicaments Containing Vitamins And Provitamins - Market Analysis, Forecast, Size, Trends And Insights
$599
Mar 1, 2025
Eye 514

This report provides an in-depth analysis of the global medicaments containing vitamins market.

U.S. - Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Mar 1, 2025
Eye 294

This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in the U.S..

U.S. - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends And Insights
$599
Mar 1, 2025
Eye 285

This report provides an in-depth analysis of the market for medicaments containing corticosteroid hormones in the U.S..

Eli Lilly Strives to Boost Zepbound Sales Despite Supply Chain Challenges
Feb 5, 2025
Eye 153

Eli Lilly is strategizing to increase Zepbound sales as they face supply chain difficulties, impacting their revenue outlook.

FDA Approves Novo Nordisk's Ozempic for Chronic Kidney Disease
Jan 28, 2025
Eye 177

The FDA has approved Novo Nordisk's Ozempic for chronic kidney disease, extending its use beyond Type 2 diabetes. This approval marks a significant advancement in managing related health conditions.

Medicare to Negotiate Prices of Weight Loss Drugs like Ozempic and Wegovy
Jan 17, 2025
Eye 87

Discover how Medicare's new price negotiations for popular weight loss drugs like Ozempic and Wegovy aim to reduce costs and impact global pharmaceutical trade.

Eli Lilly's Zepbound Now Covered by Medicare for Sleep Apnea Treatment
Jan 10, 2025
Eye 255

Discover how Eli Lilly's Zepbound received Medicare coverage for sleep apnea, offering new treatment possibilities for millions of Americans.

Top Import Markets for Penicillins and Streptomycins Medicaments
Jul 24, 2024
Eye 216

Explore the top import markets for penicillins and streptomycins medicaments based on data from the IndexBox market intelligence platform.

Import Markets for Medicaments Containing Corticosteroid Hormones
Dec 27, 2023
Eye 348

Discover the top import markets for medicaments containing corticosteroid hormones. Read about the import values and key statistics of the leading countries including the United States, Switzerland, China, and more.

World's Best Import Markets for Prophylactic Medicaments Containing Insulin
Aug 8, 2024
Eye 173

Explore the top import markets for prophylactic medicaments containing insulin, including key statistics and import values. Learn about the leading countries driving the demand for these essential healthcare products.

Mitsubishi Chooses Bain Capital for Major Pharma Deal
Jan 20, 2025
Eye 269

Mitsubishi Chemical selects Bain Capital for Tanabe Mitsubishi Pharma acquisition in a deal surpassing $3.2 billion, aiming to streamline operations.

Reckitt Benckiser to Boost US Manufacturing Amid Trade Policy Changes
Jan 15, 2025
Eye 163

Reckitt Benckiser is investing $200 million to boost US manufacturing, creating 300 jobs and reducing import dependency amid potential Trump administration tariffs.

Top Import Markets for Medicaments Containing Vitamins
Dec 7, 2024
Eye 105

Discover the top import markets for medicaments containing vitamins and the key statistics from the IndexBox market intelligence platform.

Free Data: Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - United States